Stocks
Dr. Reddy's Laboratories (RDY) EBITDA US GAAP (year values) |
|||||||||
| FY2023 | FY2024 | FY2025 | FY2026 | FY2026 | LTM ? | CAGR 5 years ? | |||
| EBITDA, ₹ | ? | 74 431 000 000 | 88 422 000 000 | 96 671 000 000 | 70 549 544 000 | 83 293 896 000 | 74 646 003 069 | ||
| Changes by years, y/y, % | +65% | +19% | +9% | -27% | +18% | +174.5% | |||
Dr. Reddy's Laboratories. EBITDA US GAAP, ₹
Dr. Reddy's Laboratories. EBITDA US GAAP, changes, %
Dr. Reddy's Laboratories. EBITDA US GAAP, sum by quarters, ₹
Dr. Reddy's Laboratories (RDY) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q3 | FY2026Q4 | LTM ? | |||
| EBITDA, ₹ | ? | 25 264 000 000 | 24 642 000 000 | 24 308 000 000 | 19 560 000 000 | 8 758 174 000 | 74 646 003 069 | |
| Changes by years, y/y, % | +24% | +13% | +2% | -19% | -65% | |||
| Changes by quarters, q/q, % | +4% | -2% | -1% | -20% | -55% | |||
